logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Erbi Biosystems Raises $4M To Provide Small-Scale Perfusion Bioreactors For Development And Manufacture Of Cell Therapies

Jan 04, 2022•almost 4 years ago

Amount Raised

$4 Million

Round Type

seed

Cambridge

Description

Erbi Biosystems, developer of innovative, small-scale, automated, and high-performance cell culture systems, has closed a private round of funding totaling $4M. This latest financing will enable the company to expand operations to meet the growing demand for its Breez perfusion bioreactor product and develop extensions to enhance cell therapy applications.

Company Information

Company

Erbi Biosystems

Location

Cambridge, Maryland, United States

About

Erbi Biosystems supports therapeutic drug manufacturers with tools to accelerate the development of their processes and therapies. Erbi's technology platform includes single-use, mL-scale cell culture, microfluidics, optical sensing, and integrated controls. The Breez bioreactor is used across a range of applications and cell types, including media and cell-line development; intensified process and n-1; CAR-T process development; and non-mammalian cell culture. The small size, single-use device, and fully automated operation drastically reduce the time, media consumption and lab space required for process development. The mL-scale working volume and closed-sterile consumable format make it ideal when working with scarce and highly variable source materials, such as autologous therapy development. The Erbi Breez system is available worldwide with sales and distribution in the US, EU, and China. SOURCE Erbi Biosystems